Mimedx (MDXG) Total Liabilities (2010 - 2026)

Mimedx (MDXG) has 17 years of Total Liabilities data on file, last reported at $65.7 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities fell 2.81% year-over-year to $65.7 million; the trailing twelve-month figure through Mar 2026 stood at $65.7 million (down 2.81% YoY), and the FY2025 full-year result was $86.1 million, up 21.6% from the prior year.
• Total Liabilities eased to $65.7 million in Q1 2026, from $86.1 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $99.8 million in Q3 2022 to a low of $62.1 million in Q2 2024.
• A 5-year average of $82.0 million and a median of $86.1 million in 2025 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities plunged 35.64% in 2024 and rose 27.29% in 2025, its largest moves.
• Tracing MDXG's Total Liabilities over 5 years: stood at $96.9 million in 2022, then retreated by 0.61% to $96.3 million in 2023, then fell by 26.49% to $70.8 million in 2024, then climbed by 21.6% to $86.1 million in 2025, then slipped by 23.65% to $65.7 million in 2026.
• Business Quant data shows MDXG's Total Liabilities at $65.7 million in Q1 2026, $86.1 million in Q4 2025, and $80.0 million in Q3 2025.